What is the 13F Pro Quality Score for EDVA?

13F Pro ranks Endovia Health Sciences, Inc. (EDVA) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View EDVA's current score at https://13fpro.ai/company/EDVA (free sign-up required for the full ranking).

Which hedge funds own the most EDVA stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of EDVA include JANE STREET GROUP,, Phraction Management, Summit Trail Advisors,. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/company/EDVA as soon as new 13F filings post.

Where does 13F Pro source EDVA data?

All Endovia Health Sciences, Inc. fundamentals and ownership data come directly from SEC EDGAR. Endovia Health Sciences, Inc. files with the SEC under CIK 1553788. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is EDVA in?

Endovia Health Sciences, Inc. (EDVA) is classified in the Consumer Staples sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/consumer-staples.

How often is EDVA research updated on 13F Pro?

EDVA's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Endovia Health Sciences, Inc.(EDVA)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Consumer Staples →NYSEsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1553788 EDVA stock profile & AI dashboard →

13F Pro Quality Score

15.0/100

Rank #2,857 of 2,962 stocks

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why EDVA Scores 15/100

exact factor attribution · 2026-09-11

EDVA's composite is driven by earnings growth, held back by revenue growth and scale. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Earnings growth

+2.0 pts

91th pct

Institutional flow

+0.5 pts

61th pct

Shareholder dilution

-2.5 pts

0th pct

Earnings quality

-3.8 pts

12th pct

Capital efficiency

-4.8 pts

2th pct

Free cash flow

-5.2 pts

15th pct

Profitability

-5.8 pts

11th pct

Scale

-6.4 pts

8th pct

Revenue growth

-9.2 pts

4th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

EDVA Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Endovia Health Sciences, Inc. (EDVA), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores EDVA at 15.0/100 on a 32-signal composite quality model, placing it at rank #2,857 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of EDVA by reported 13-F value include JANE STREET GROUP, Phraction Management, Summit Trail Advisors, based on the most recent SEC filings. EDVA trades on the NYSE exchange and files with the SEC under CIK 1553788. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EDVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Endovia Health Sciences, Inc. directly from SEC EDGAR. Endovia Health Sciences, Inc.'s 13F Pro composite quality score has ranged between 6 and 20 since 2026, currently 15.0 — an improving long-term trajectory across 9 quarterly and live scoring snapshots.

Revenue

Q2 2026

$0.00

Net Income

Q2 2026

$-2.1M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

-90.9% YoY

$73.1KFY 2025

FY22 $18.1MFY23 $18.9MFY24 $801.3KFY25 $73.1K

Net Income

-6.2% YoY

$-25.2MFY 2025

FY22 $-21.7MFY23 $-21.0MFY24 $-23.8MFY25 $-25.2M

Operating Income

-43.3% YoY

$-14.2MFY 2025

FY22 $-21.4MFY23 $-15.3MFY24 $-9.9MFY25 $-14.2M

EPS (Diluted)

+32.3% YoY

$-11.97FY 2025

FY22 —FY23 —FY24 $-17.68FY25 $-11.97

Total Assets

-65.0% YoY

$965.7KFY 2025

FY22 $17.3MFY23 $9.9MFY24 $2.8MFY25 $965.7K

Total Debt

-99.8% YoY

$3.4KFY 2025

FY22 $2.5MFY23 $457.7KFY24 $2.0MFY25 $3.4K

Op. Cash Flow

+34.0% YoY

$-4.8MFY 2025

FY22 $-14.0MFY23 $-10.2MFY24 $-7.3MFY25 $-4.8M

Free Cash Flow

—FY 2025

FY22 $-14.1MFY23 $-10.2MFY24 $-7.3MFY25 —

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$73.1K -90.9%	$801.3K -95.7%	$18.9M +4.2%	$18.1M +59.8%	$11.3M +280.2%	$3.0M
Net Income	$-25.2M -6.2%	$-23.8M -13.1%	$-21.0M +3.2%	$-21.7M +25.3%	$-29.1M -1.3%	$-28.7M
Operating Income	$-14.2M -43.3%	$-9.9M +35.2%	$-15.3M +28.5%	$-21.4M +26.4%	$-29.1M -64.7%	$-17.7M
EPS (Diluted)	$-11.97 +32.3%	$-17.68	—	—	$-1.02 +3.8%	$-1.06
Total Assets	$965.7K -65.0%	$2.8M -72.1%	$9.9M -42.8%	$17.3M +5.6%	$16.4M +77.6%	$9.2M
Total Debt	$3.4K -99.8%	$2.0M +330.7%	$457.7K -82.0%	$2.5M	$0.00 -100.0%	$1.2M
Operating Cash Flow	$-4.8M +34.0%	$-7.3M +28.3%	$-10.2M +27.4%	$-14.0M +4.5%	$-14.7M +31.1%	$-21.3M
Free Cash Flow	—	$-7.3M +28.4%	$-10.2M +27.9%	$-14.1M +3.8%	$-14.7M +31.3%	$-21.4M

Get alerted when EDVA's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Endovia Health Sciences, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of EDVA

JANE STREET GROUP, LLC
$54.0K348,418 sh
Phraction Management LLC
$19.2K123,648 sh
Summit Trail Advisors, LLC
$15.5K100,000 sh
GEODE CAPITAL MANAGEMENT, LLC
$10.6K68,591 sh
TRUIST FINANCIAL CORP
$10.5K67,819 sh
Lifetime Wealth Management P.C.
$10.2K66,050 sh
COMPASS FINANCIAL MANAGEMENT LLC
$10.0K64,500 sh
Virtu Financial LLC
$9.0K59,897 sh
Point72 Asset Management, L.P.
$8.8K56,950 sh
HRT FINANCIAL LP
$8.0K56,687 sh

Fund	Value	Shares
JANE STREET GROUP, LLC	$54.0K	348,418
Phraction Management LLC	$19.2K	123,648
Summit Trail Advisors, LLC	$15.5K	100,000
GEODE CAPITAL MANAGEMENT, LLC	$10.6K	68,591
TRUIST FINANCIAL CORP	$10.5K	67,819
Lifetime Wealth Management P.C.	$10.2K	66,050
COMPASS FINANCIAL MANAGEMENT LLC	$10.0K	64,500
Virtu Financial LLC	$9.0K	59,897
Point72 Asset Management, L.P.	$8.8K	56,950
HRT FINANCIAL LP	$8.0K	56,687

More Consumer Staples Companies

View all Consumer Staples →

ABEV

AMBEV S.A.

ABVE

Above Food Ingredients Inc.

ACI

Albertsons Companies, Inc.

ADM

Archer-Daniels-Midland Co

AFRI

Forafric Global PLC

AGCC

Agencia Comercial Spirits Ltd.

AGRO

Adecoagro S.A.

AGRZ

Agroz Inc.

Put EDVA on your watchlist

Track score changes the day Endovia Health Sciences, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is EDVA a good stock to buy?

13F Pro's AI-powered analysis of Endovia Health Sciences, Inc. (EDVA) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for EDVA are available on the EDVA stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. EDVA is classified as a small company.

Which hedge funds own EDVA?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling EDVA. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Endovia Health Sciences, Inc.'s investment landscape.